Skip to main content
Clinical Trials/NCT01808209
NCT01808209CompletedNot Applicable

Clinical Performance of Stenfilcon A Versus Filcon II 3

Coopervision, Inc.1 site in 1 country60 target enrollmentStarted: January 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Comfort

Study Overview

Brief Summary

Clinical Performance of Stenfilcon vs. Filcon II 3

Detailed Description

The objective of this study is to compare the comfort and clinical performance of Stenfilcon vs. Filcon II 3 compared to subject's habitual contact lenses. The null hypothesis is that there is no difference in the clinical performance between the two sets of lenses.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Subjects must satisfy the following conditions prior to inclusion in the study:
  • •Based on his/her knowledge, must be in good general health. Be of legal age (18 years) or older.
  • •Be able and willing to adhere to the instructions set forth in this protocol and complete all specified evaluation.
  • •Read, indicate understanding of, and sign Written Informed Consent (Appendix 1)
  • •Require a contact lens prescription between -0.50 and -6.00 and have no more than -.75dioptor (D) of astigmatism in both eyes
  • •Achieve visual acuity of 6/9 or better in each eye with a spherical contact lens prescription.
  • •An existing soft contact lens wearer of any modality.
  • •Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per day, assuming there are no contraindications for doing so.
  • •Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
  • •No amblyopia.
  • •No evidence of lid abnormality or infection (e.g. entropion, ectropion, chalazia, recurrent styes).
  • •No clinically significant slit lamp findings (e.g. infiltrates or other slit lamp findings greater than Grade 2: corneal edema, tarsal abnormalities, and conjunctival injection).
  • •No other active ocular disease (e.g. glaucoma, history of recurrent corneal erosions, cornea [infiltrates], conjunctiva, lids, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology.)
  • •No aphakia

Exclusion Criteria

  • •Any of the following will render a subject ineligible for inclusion:
  • •Neophytes, who have not worn lenses before
  • •Greater than 0.75D of refractive astigmatism in either eye
  • •Presence of clinically significant (grade 3 or above) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
  • •Presence of ocular or systemic disease or need of medication which might interfere with contact lens wear.
  • •Slit lamp findings that would contraindicate contact lens wear such as:
  • •Pathological dry eye or associated findings
  • •Pterygium, pinguecula or corneal scars within the visual axis
  • •Neovascularization > 0.75 mm in from the limbus
  • •Giant papillary conjunctivitis (GPC) Grade 3 or above
  • •Anterior uveitis or iritis (past or present)
  • •Seborrheic eczema, seborrheic conjunctivitis
  • •History of corneal ulcer or fungal infections
  • •Poor personal hygiene
  • •A known history of corneal hypoesthesia (reduced corneal sensitivity).
  • •Contact lens best corrected Snellen visual acuities (VA) worse than 6/9
  • •Aphakia, Keratoconus or a highly irregular cornea

Arms & Interventions

stenfilcon A

Experimental

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Intervention: filcon II 3 (Device)

filcon II 3

Active Comparator

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Intervention: stenfilcon A (Device)

Outcomes

Primary Outcomes

Comfort

Time Frame: 1 Week

Participant rating for comfort. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).

Daily and Comfortable Wearing Time

Time Frame: 1 week

Participant rating of lens Daily and Comfortable Wearing Time. Collected at 1 week wear for each lens.(The hours of average comfortable wearing time and average daily wearing time.)

Dryness

Time Frame: 1 Week

Participant rating for dryness. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).

Eye Whiteness

Time Frame: 1 Week

Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).

Overall Satisfaction

Time Frame: 1 Week

Participant rating for overall satisfaction. Collected at 1 week for study lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).

Visual Acuity logMAR

Time Frame: 1 Week

Assessment of Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at 1 week for study lenses. logMAR

Wettability

Time Frame: 1 Week

Participant rating for surface wettability. Collected at 1 week. Tear film analysis in seconds.

Handling

Time Frame: 1 Week

Participant rating for lens handling. Collected at 1 week. (Insertion: 0-100, 0= could not get it in and 100= went in without a problem. Removal: 0= could not get it out and 100= came out without a problem. Blister: 0=impossible and 100=came out extremely easily).

Vision Quality

Time Frame: 1 Week

Participant rating of vision quality. Collected at 1 week. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)

Daily and Comfortable Wearing Time

Time Frame: Baseline

Participant rating of lens Daily and Comfortable Wearing Time. Collected at baseline for all habitual lenses.(The hours of average comfortable wearing time and average daily wearing time.)

Vision Quality

Time Frame: Baseline

Participant rating of vision quality. Collected at baseline for habitual lens. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)

Comfort

Time Frame: Baseline

Participant rating of lens comfort. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable,100=extreme comfort / cannot feel them at all)

Dryness

Time Frame: Baseline

Participant rating of lens dryness. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable, 100=extreme comfort/ cannot feel them at all)

Eye Whiteness

Time Frame: Baseline

Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).

Overall Satisfaction

Time Frame: Baseline

Participant rating for overall satisfaction. Collected at baseline for habitual lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).

Visual Acuity logMAR

Time Frame: Baseline

Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at baseline for habitual lens. logMAR.

Visual Acuity logMAR

Time Frame: Dispense

Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at dispense for study lenses. logMAR.

Secondary Outcomes

  • Blood Vessel Coverage(1 Week)
  • Corneal Staining(1 Week)
  • Conjunctival Staining(1 Week)
  • Conjunctival Redness(1 Week)
  • Blood Vessel Coverage(Baseline)
  • Conjunctival Redness(Baseline)
  • Corneal Staining(Baseline)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Clinical Performance of Stenfilcon A... | Clinical Trial